Detailed price information for Novo Nordisk A/S ADR (NVO-N) from The Globe and Mail including charting and trades.

Detailed price information for Novo Nordisk A/S ADR (NVO-N) from The Globe and Mail including charting and trades.

NVO CEO exits amid pressure. Sanofi is set to buy VIGL. Pfizer inks $1.25B 3SBio deal. FDA okays Roche eye drug for new indication. Merck starts key cancer study.

A federal deadline ending sale of off-brand weight-loss and diabetes medications is now in effect, cutting off access to ...

How a new Trump plan could make science ‘a political football’ The NIH is already in turmoil. Billlions of dol ...

Under a mutual agreement with the board of directors, longtime Novo Nordisk CEO Lars Fruergaard Jørgensen—who recently ...

Lawndale Christian Health Center (LCHC) recently announced the planned retirement of current CEO, Bruce E. Miller. Mr. Miller’s career at LCHC began in 1998 when he served as the organization’s Chief ...